Wynne Sarah's Form 4 filing
TransDigm Group INC (TDG) · filed Feb 23, 2024
- Accession no.
- 0000950170-24-019134
- Filed
- Feb 23, 2024
- Trade date
- Feb 21, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 7 non-derivative transactions and 2 derivative transactions. Open-market sales total $6.78M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wynne SarahCIK 0001758252 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2024 | Common Stock | MOption exerciseAcquired | +5,850 | $347.17 | +$2,030,944.5 | 6,550 | Direct | |
| Feb 21, 2024 | Common Stock | SSaleDisposed | −786 | $1,156.88F1 | −$909,307.68 | 5,764 | Direct | |
| Feb 21, 2024 | Common Stock | SSaleDisposed | −970 | $1,158.01F2 | −$1,123,269.7 | 4,794 | Direct | |
| Feb 21, 2024 | Common Stock | SSaleDisposed | −1,920 | $1,158.95F3 | −$2,225,184 | 2,874 | Direct | |
| Feb 21, 2024 | Common Stock | SSaleDisposed | −2,044 | $1,160.18F4 | −$2,371,407.92 | 830 | Direct | |
| Feb 21, 2024 | Common Stock | SSaleDisposed | −130 | $1,161.30 | −$150,969 | 700 | Direct | |
| Feb 21, 2024 | Common Stock | MOption exerciseAcquired | +2,700 | $269.42 | +$727,434 | 3,400 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2024 | Common Stock | MOption exerciseDisposed | −5,850 | $0.00 | $0 | 0 | Direct | |
| Feb 21, 2024 | Common Stock | MOption exerciseDisposed | −2,700 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,156.5000 - $1,157.4800. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,157.5700 - $1,158.5550. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,158.6000 - $1,159.2000. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,159.8600 - $1,160.5950. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.